|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 31, 2006 |
||
|
||
GENTA INCORPORATED |
||
(Exact Name of Registrant as Specified in Its Charter) |
||
|
||
Delaware |
||
|
||
0-19635 |
|
33-0326866 |
|
||
200 Connell Drive |
|
07922 |
|
||
|
(908) 286-9800 |
|
(Registrants Telephone Number, Including Area Code) |
||
|
||
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 8.01 Other Events.
On October 31, 2006, Genta Incorporated (NASDAQ: GNTA) issued a press release announcing that target patient accrual has been completed into a randomized Phase 3 trial of Genasense® plus chemotherapy in previously untreated patients with acute myeloid leukemia (AML).
The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Form 8-K shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit |
Description |
|||
99.1 |
Press Release of the Company dated October 31, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
GENTA INCORPORATED |
|||
Date: |
October 31, 2006 |
|
By: |
/s/ RICHARD J. MORAN |
|
|
|
|
|
Name: |
Richard J. Moran |
|
|
|
|
Title: |
Senior Vice President, Chief Financial Officer and Corporate Secretary |
EXHIBIT INDEX
Exhibit |
Description |
Sequentially |
99.1 |
Press Release of the Company dated October 31, 2006
|
|